参考資料
JAPICによる学会発表
アカデミア機関による研究成果発表
アカデミアの方々を対象に価格を抑えてJAPIC FAERSデータを提供し,研究活動にご利用いただいております。
以下に本サービスを用いた研究成果・公表論文等をご紹介します(一部)。
- 2023
- Onda K, Honma T, Masuyama K.
Methotrexate-related adverse events and impact of concomitant treatment with folic acid and tumor necrosis factor-alpha inhibitors: An assessment using the FDA adverse event reporting system Frontiers in Pharmacology 2023; DOI: 10.3389/fphar.2023.1030832
- 2023
- Kamimura H, Setsu T, Kimura N, Miyazawa M, Kaneko S, Kamimura K, Tsuchiya A, Uesawa Y, Terai S
Analysis of drug-induced liver-related adverse event trend reporting between 1997 and 2019.
Hepatology Research 2023; DOI: 10.1111/hepr.13883
- 2022
- Sakai T, Mori C, Ohtsu F
Potential safety signal of pregnancy loss with vascular endothelial growth factor inhibitor intraocular injection: A disproportionality analysis using the Food and Drug Administration Adverse Event Reporting System.
Frontiers in Pharmacology 2022; DOI: 10.3389/fphar.2022.1063625
- 2021
- Sakai T, Mori C, Koshiba H, Yuminaga R, Tanabe K, Ohtsu F
Pregnancy Loss Signal from Prostaglandin Eye Drop Use in Pregnancy: A Disproportionality Analysis Using Japanese and US Spontaneous Reporting Databases.
Drugs - Real World Outcomes 2021; DOI: 10.1007/s40801-021-00287-y
- Fukazawa C, Hinomura Y, Kaneko M, Narukawa M.
Factors Influencing Regulatory Decision-Making in Signal Management: Analysis Based on the Signals Identified from the FAERS
Therapeutic Innovation & Regulatory Science 2021; DOI:10.1007/s43441-021-00265-0
- Kan Y, Nagai J, Uesawa Y.
Evaluation of antibiotic-induced taste and smell disorders using the FDA adverse event reporting system database.
Scientific Reports 2021; DOI: 10.1038/s41598-021-88958-2
- 2019
- Toki T, Ono S.
Assessment of factors associated with completeness of spontaneous adverse event reporting in the United States: a comparison between consumer reports and healthcare professional reports.
Journal of Clinical Pharmacy & Therapeutics 2019; DOI:10.1111/jcpt.13086
- 2018
- Toki T, Ono S.
Spontaneous reporting on adverse events by consumers in the United States: An analysis of the Food and Drug Administration adverse event reporting system database.
Drugs - Real World Outcomes 2018; DOI:10.1007/s40801-018-0134-0
- Fukazawa C, Hinomura Y, Kaneko M, Narukawa M.
Significance of data mining in routine signal detection: Analysis based on the safety signals identified by the FDA
Pharmacoepidemiology and Drug Safety 2018; DOI: 10.1002/pds.4672
|